Join Us for the Bayer Expert Monday Series!
Attention Innovators and Early Stage Entrepreneurs! Do you have disruptive science but struggle to bring it to life in the entrepreneurial world? Bayer's passion is to enable and support standout healthcare innovation!
Bayer is excited to launch the 2025 Bayer Expert Monday series, designed specifically for innovative minds in the life sciences. This virtual series will provide you with exclusive access to Bayer experts who will share their invaluable insights, experiences, and guidance to help you navigate the complexities of pharmaceutical development.
Over the last two years, Bayer's Expert Mondays brought together over 5,000 innovators across 23 sessions. Let's build on this success and continue to bring breakthrough innovation to patients.
What to Expect:
- Expert Insights: Each session will feature a leading expert from Bayer, covering a range of topics including drug discovery, regulatory pathways, clinical trials, and commercialization strategies, with a focus on our strategic areas of interest: oncology, cell and gene therapy, cardiovascular/renal, and immunology.
- Interactive Q&A: Engage directly with our experts during live Q&A sessions, allowing you to ask your most pressing questions and gain tailored advice for your entrepreneurial journey.
- Networking Opportunities: Connect with fellow early stage entrepreneurs and build valuable relationships within the pharmaceutical community.
Upcoming Sessions
Strategic Interest in External Innovation: Data Science
May 19, 2025
Matteo Aldeghi
Senior Director, Machine Learning Research
Bayer Pharmaceuticals
Gurpreet Singh
Senior Director, Head, Applied Machine Learning
Bayer Pharmaceuticals
A Roadmap through the EU and the US
Cell & Gene Therapy Regulatory Jungle
June 2, 2025
Bernadette Bosse
Global Regulatory Strategist
Bayer Pharmaceuticals
Strategic Interests in
External Innovation: Vividion
June 9, 2025
Matt Patricelli, PhD
Chief Scientific Officer
Vividion Therapeutics
Ingredients to Success: How to Measure, Evaluate and Drive the Success of Partnerships?
June 23, 2025
Nicolas Becker
Sr. Director Business Development & Licensing / Alliance Management
Bayer Pharmaceuticals
Joao Schumann
Alliance Manager
Bayer Pharmaceuticals
Future sessions and featured experts will be announced throughout the year, so be sure to check back regularly for updates!
What you need to know:
- Each one-hour Bayer's Expert Monday includes a live Q&A with respective Bayer Experts.
- These sessions are not intended for service providers, consultants, IT providers, etc. They are designed for drug developers and healthcare researchers seeking collaboration with big pharma and out-licensing opportunities later in their journey.
- Session recordings are NOT distributed afterward. Live attendance is necessary to get the most out of the expert sessions and network with the Bayer Pharma team.
- Each session has a maximum capacity of 500 participants.
Want to know when new sessions are added? Join our invite list today!
Past Sessions
Streamlining Clinical Trials:
Overcoming Complexity and Enhancing Efficiency in Biopharma R&D
March 3, 2025
Dr. Bernhard Glombitza
Head Clinical Operations & Customer Engagement EMEA & LATAM, VP
Bayer Pharmaceuticals
Global Deal Trends
April 7, 2025
Dr. Yan Jiang
Sr. Dir, Business Development & Licensing, BD insights Deal Analysis
Bayer Pharmaceuticals
Capital Connect: What Attracts VCs,
Investment Banks, and Pharma Investors
May 5, 2025
Rakhshita Dhar
Venture Investments, Pharma
Leaps by Bayer